Amneal Pharmaceuticals, Inc. (AMRX) Net Income (Loss) Attributable to Parent USD 2016 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Amneal Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2016 to 2023.
  • Amneal Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$91.6 M, a 1220% decline year-over-year.
  • Amneal Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$164 M, a 39% increase year-over-year.
  • Amneal Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$79.3 M, a 70.7% increase from 2022.
  • Amneal Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$271 M, a 2156% decline from 2021.
  • Amneal Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $13.2 M, a 80.6% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$79.3 M +$191 M +70.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 -$271 M -$284 M -2156% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $13.2 M -$54.6 M -80.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 $67.8 M +$671 M Jan 1, 2020 Dec 31, 2020 10-K 2023-03-03
2019 -$604 M -$584 M -2957% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$19.7 M -$19.7 M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $0 $0 Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $0 Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.